Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Reading Center Evaluation of OCT Images From Patients Enrolled in the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study

Go back to Resources

Reading Center Evaluation of OCT Images From Patients Enrolled in the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study

Authors:

Location:

Go back to Resources

Association between Dietary Glycemic Index and Age-Related Macular Degeneration in Nondiabetic Participants in the Age-Related Eye Disease Study (AREDS)

Go back to Resources

Association between Dietary Glycemic Index and Age-Related Macular Degeneration in Nondiabetic Participants in the Age-Related Eye Disease Study (AREDS)

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

An Approach to Development and Dissemination of Patient Recruitment Materials for a Large Multi-Center Clinical Trial

Go back to Resources

An Approach to Development and Dissemination of Patient Recruitment Materials for a Large Multi-Center Clinical Trial

Authors:

Secondary:

Location:

Go back to Resources

A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine

Go back to Resources

A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine

Authors:

Secondary:

Location:

URL:

Go back to Resources

A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine

Go back to Resources

A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine

Authors:

Secondary:

Location:

URL:

Go back to Resources

Younger Age and Antibody Induction Increase the Risk for Infection in Pediatric Renal Transplantation: A NAPRTCS Report

Go back to Resources

Younger Age and Antibody Induction Increase the Risk for Infection in Pediatric Renal Transplantation: A NAPRTCS Report

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity

Go back to Resources

Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Second Annual Analysis of the Collaborative Islet Transplant Registry

Go back to Resources

Second Annual Analysis of the Collaborative Islet Transplant Registry

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Safety, Immunogenicity and Efficacy of Modified Vaccinia Ankara (MVA) Against Dryvax Challenge in Vaccinia-Naive and Vaccinia-Immune Individuals

Go back to Resources

Safety, Immunogenicity and Efficacy of Modified Vaccinia Ankara (MVA) Against Dryvax Challenge in Vaccinia-Naive and Vaccinia-Immune Individuals

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina

Go back to Resources

Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 165
  • Page 166
  • Page 167
  • Page 168
  • Current page 169
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification